background
viral
aetiolog
common
caus
central
nervou
system
cn
infect
approxim
onehalf
cn
infect
remain
undetermin
origin
highthroughput
sequenc
ht
brought
new
perspect
cn
infect
investig
allow
investig
viral
aetiolog
unbias
approach
ht
use
still
limit
specif
clinic
situat
object
aim
review
evalu
contribut
pitfal
ht
aetiolog
identif
viral
enceph
meningoenceph
mening
cn
patient
sampl
sourc
pubm
search
januari
august
retriev
avail
studi
topic
addit
public
includ
review
fulltext
sourc
content
among
studi
retriev
use
ht
diagnost
techniqu
ht
perform
cerebrospin
fluid
brain
biopsi
sampl
patient
includ
immunocompromis
immunocompet
paediatr
adult
case
ht
perform
retrospect
studi
prospect
ht
led
identif
potenti
causal
viru
patient
virus
known
ten
expect
caus
cn
infect
variou
ht
protocol
use
implic
addit
valu
ht
difficult
quantifi
variou
bias
nevertheless
ht
led
identif
viral
caus
enceph
meningoenceph
mening
case
variou
assay
fail
identifi
caus
ht
consid
earli
clinic
manag
complement
routin
assay
standard
strategi
systemat
studi
need
integr
ht
clinic
manag
mc
zanella
clin
microbiol
infect
mening
enceph
meningoenceph
caus
variou
pathogen
viral
aetiolog
common
caus
among
enteroviru
ev
herp
simplex
type
varicella
zoster
viru
vzv
frequent
virus
associ
enceph
meningoenceph
mening
paediatr
adult
popul
preval
virus
vari
accord
geograph
locat
immun
statu
patient
last
two
decad
implement
molecular
assay
complement
serolog
assay
immunohistochemistri
cultur
improv
diagnosi
viral
central
nervou
system
cn
infect
nevertheless
assay
limit
target
approach
apart
technic
limit
diagnosi
viral
cn
infect
subject
sever
issu
type
sampl
cerebrospin
fluid
csf
brain
biopsi
timelin
sampl
collect
differ
pathogen
mechan
virus
despit
technic
progress
approxim
onehalf
enceph
meningoenceph
mening
case
remain
unknown
origin
highthroughput
sequenc
ht
brought
new
perspect
cn
infect
investig
although
ht
recent
integr
enceph
manag
guidelin
use
still
limit
specif
clinic
situat
research
contribut
ht
warrant
better
apprais
implement
cn
infect
manag
narr
review
aim
evalu
contribut
pitfal
ht
aetiolog
identif
viral
enceph
meningoenceph
enceph
paediatr
adult
patient
comprehens
pubm
search
conduct
januari
august
identifi
human
studi
use
follow
mesh
keyword
research
algorithm
central
nervou
system
infect
cerebrospin
fluid
central
nervou
system
sequenc
viru
addit
public
identifi
review
fulltext
sourc
titl
abstract
citat
screen
two
review
assess
elig
detail
analysi
inclus
criteria
studi
includ
patient
enceph
meningoenceph
mening
unknown
origin
report
use
ht
aetiolog
identif
viral
origin
cn
sampl
exclus
criteria
review
anim
studi
cn
diseas
studi
address
technic
aspect
total
refer
retriev
fig
twentynin
studi
select
qualit
analysi
case
report
ten
case
seri
tabl
fourteen
studi
concern
paediatr
adult
case
respect
two
studi
concern
popul
tabl
ht
perform
case
adult
paediatr
year
case
inform
age
twentyf
studi
report
patient
age
median
age
year
rang
month
year
diagnost
criteria
enceph
meningoenceph
mening
inconsist
report
immun
statu
report
patient
compris
immunocompromis
nine
paediatr
adult
immunocompet
patient
paediatr
eight
adult
studi
came
wide
rang
region
europ
ten
north
america
ten
asia
six
oceania
three
tabl
brain
specimen
avail
patholog
examin
provid
proof
diagnosi
enceph
csf
analysi
result
report
patient
studi
white
blood
cell
count
rang
cellmm
enceph
meningoenceph
case
cellmm
mening
case
three
public
report
normal
csf
analysi
without
descript
ht
perform
individu
csf
brain
specimen
patient
respect
csf
sampl
patient
pool
ht
analysi
ht
perform
csf
brain
specimen
five
patient
posit
result
sampl
obtain
cach
valley
viru
chronic
meningoenceph
case
posit
result
brain
biopsi
report
two
human
astroviru
hastv
tickborn
enceph
tbev
case
one
patient
ht
analysi
identifi
viral
caus
balamuthia
mandrillari
identifi
csf
brain
biopsi
despit
limit
public
bia
overal
diagnost
yield
viral
aetiolog
accord
sampl
type
estim
higher
brain
specimen
posit
sampl
csf
sampl
posit
sampl
detail
microbiolog
investig
perform
prior
ht
vari
accord
local
practic
report
seven
studi
studi
virus
identifi
ht
part
microbiolog
workup
except
three
case
ht
identifi
viru
diagnost
assay
neg
routin
investig
includ
west
nile
viru
wnv
identifi
csf
sampl
renal
transplant
recipi
meningoenceph
neg
serolog
assay
identifi
enceph
case
vaccin
strain
mump
viru
identifi
brain
specimen
immunosuppress
child
chronic
enceph
rt
pcr
mump
csf
sampl
neg
assay
target
vaccin
strain
ht
perform
retrospect
studi
prospect
part
initi
workup
case
report
impact
clinic
manag
three
immunocompromis
patient
child
enceph
associ
adult
enceph
associ
adult
chronic
meningoenceph
associ
cach
valley
viru
turnaround
time
report
ten
studi
among
public
ht
use
prospect
turnaround
time
rang
hour
day
ht
perform
pool
individu
sampl
andor
subsequ
confirmatori
assay
allow
identif
potenti
causal
viru
patient
compris
paediatr
case
eight
immunocompromis
case
adult
case
nine
immunocompromis
case
nine
case
age
specifi
median
age
year
rang
month
year
fig
show
distribut
virus
identifi
accord
patient
immun
statu
clinic
manifest
ht
allow
identif
virus
previous
unknown
unexpect
caus
cn
infect
n
thu
screen
diagnost
investig
tabl
includ
parvoviru
two
human
coronaviru
one
novel
one
identifi
immunocompet
patient
mump
viru
vaccin
strain
one
hastv
undetermin
speci
one
four
one
identifi
immunocompromis
patient
gemycircularviru
also
identifi
causal
role
enceph
debat
three
novel
viral
speci
strain
identifi
csf
sampl
patient
enceph
tabl
human
csfassoci
densoviru
cycloviru
vietnam
cycvvn
lymphocyt
choriomening
viru
lcmv
relat
arenaviru
ht
analysi
also
identifi
virus
known
respons
cn
infect
n
screen
detect
routin
assay
vzv
epsteinebarr
viru
ebv
tbev
wnv
cach
valley
saint
loui
enceph
toscana
mump
measl
coxsacki
viru
tabl
studi
perform
nucleic
acid
extract
protocol
dedic
rna
rna
dna
thirteen
rna
seven
dna
viral
speci
identifi
tabl
one
studi
report
identif
csf
sampl
rna
extract
protocol
six
studi
ht
analysi
restrict
detect
virus
result
identif
bacteri
brucella
melitensi
leptospira
santarosai
mycobacteri
mycobacterium
tuberculosi
parasit
balamuthia
mandrillari
fungal
candida
tropicali
fusarium
solani
oxysporum
pathogen
use
control
systemat
report
nine
studi
report
variou
neg
control
sampl
brain
specimen
without
enceph
csf
sampl
patient
without
infect
serum
sampl
water
elut
buffer
viral
sequenc
neg
control
consist
describ
posit
control
csf
serum
sampl
posit
dna
rna
virus
rare
report
use
address
specif
ht
result
techniqu
perform
confirm
ht
result
studi
except
one
rt
pcr
assay
perform
sampl
patient
posit
least
one
sampl
patient
ht
result
also
confirm
serolog
assay
immunohistochemistri
situ
hybrid
viral
cultur
confirm
presenc
replic
saint
loui
enceph
viru
csf
sampl
unsuccess
concern
cach
valley
viru
ht
offer
possibl
investig
viral
aetiolog
cn
infect
unbias
approach
workup
accord
guidelin
fail
identifi
causal
pathogen
base
studi
retriev
diagnost
yield
viral
aetiolog
difficult
estim
particularli
public
bia
high
number
case
report
methodolog
heterogen
lack
systemat
prospect
studi
focus
specif
case
seri
diagnost
yield
identif
viral
caus
approxim
result
interpret
caution
light
evolut
techniqu
among
studi
review
ht
contribut
evid
identif
potenti
causal
viru
cn
infect
unknown
origin
also
detect
novel
diverg
virus
similar
techniqu
type
sampl
use
analysi
particular
import
despit
divers
ht
protocol
public
bia
ht
seem
higher
diagnost
yield
brain
specimen
csf
sampl
diagnost
yield
particularli
low
two
studi
ht
perform
csf
supernat
ht
also
show
clinic
valu
situat
viral
pathogen
mechan
specif
clinic
situat
impair
result
convent
assay
among
immunocompet
patient
ht
led
identif
virus
previous
associ
cn
infect
parvoviru
cycvvn
gemycircularviru
novel
ht
clinic
impact
mainli
demonstr
among
immunocompromis
patient
studi
dedic
popul
perform
prospect
case
led
chang
clinic
manag
three
rapid
decis
perform
ht
short
ht
turnaround
time
effici
interpret
result
determin
manag
latter
patient
among
immunocompromis
patient
ht
contribut
detect
virus
assay
perform
convent
workup
virus
known
caus
cn
infect
tbev
wnv
cach
valley
viru
saintloui
enceph
viru
ebv
virus
known
respons
cn
infect
novel
human
coronaviru
mump
viru
vaccin
strain
novel
virus
lcmvrelat
arenaviru
focus
novel
hastv
ht
brought
new
insight
understand
associ
cn
infect
furthermor
rt
pcr
assay
perform
retrospect
confirm
ht
result
thu
highlight
specif
ht
absenc
standard
methodolog
heterogen
studi
strike
concern
preanalyt
step
also
ht
per
se
use
divers
ht
platform
singl
pair
protocol
well
divers
bioinformat
pipelin
databas
use
posit
control
qualiti
control
report
seven
studi
address
issu
contamin
studi
report
use
neg
control
viral
sequenc
assign
virus
consid
caus
cn
infect
consist
perform
studi
provid
descript
one
cn
sampl
viral
sequenc
interpret
result
explicitli
provid
among
read
virus
known
caus
infect
human
anellovirida
herpesvirida
describ
four
seven
sampl
respect
human
pegiviru
read
identifi
one
sampl
genom
torqu
teno
viru
member
anellovirida
famili
human
pegiviru
identifi
cn
sampl
without
associ
cn
diseas
far
viral
sequenc
mostli
assign
virus
infect
plant
nonvertebr
consid
reagent
contamin
minim
descript
ht
background
result
impair
comprehens
composit
cn
virom
furthermor
integr
ht
result
clinic
context
particular
import
absenc
standard
report
method
preclud
object
interpret
result
final
htsneg
result
could
interpret
context
sever
clinic
technic
aspect
could
impact
sensit
method
first
clinic
point
view
differ
diagnost
yield
biopsi
compar
csf
sampl
could
explain
sever
factor
patient
select
case
enceph
type
sampl
eg
multipl
pool
postmortem
brain
sampl
timelin
sampl
context
enceph
biopsi
posit
could
possibl
less
affect
time
csf
technic
point
view
consid
narr
review
includ
studi
thu
take
account
tremend
evolut
ht
techniqu
last
decad
sever
technic
issu
need
consid
interpret
neg
result
preanalyt
step
eg
use
fresh
frozen
paraffinembed
sampl
analysi
extract
protocol
fragment
method
librari
prepar
pairedend
versu
singleend
protocol
sequenc
depth
sequenc
platform
tabl
analysi
ht
raw
data
eg
map
softwar
viral
databas
pipelin
precis
review
highlight
use
ht
investig
concern
viral
caus
enceph
meningoenceph
mening
could
extend
immunocompromis
also
immunocompet
patient
consid
select
public
bia
literatur
review
neg
predict
valu
aetiolog
identif
viral
enceph
meningoenceph
mening
difficult
quantifi
studi
need
ht
need
integr
clinic
manag
secondlin
techniqu
parallel
firstlin
investig
standard
workup
accord
guidelin
addit
investig
consid
local
epidemiolog
specif
clinic
situat
fail
identifi
causal
agent
brain
biopsi
also
consid
furthermor
ht
particular
interest
screen
larg
panel
virus
particularli
avoid
restrict
screen
lowvolum
clinic
sampl
paediatr
patient
ht
brought
new
perspect
investig
infecti
diseas
notabl
unbias
approach
particular
interest
sampl
would
usual
test
specif
syndrom
use
may
restrict
cn
sampl
also
extend
clinic
sampl
illustr
posit
result
rt
pcr
assay
perform
blood
plasma
sampl
collect
time
neurolog
manifest
allow
identif
viru
detect
ht
cn
sampl
parvoviru
lcmvrelat
arenaviru
novel
novel
could
particular
interest
cerebr
biopsi
perform
dissemin
infect
occur
suspect
particularli
immunocompromis
patient
earli
decis
perform
ht
short
ht
turnaround
time
effici
interpret
result
major
issu
allow
ht
contribut
clinic
manag
prospect
ht
use
clinic
routin
timefram
short
possibl
clinic
decisionmak
among
public
ht
use
prospect
report
turnaround
time
rang
hour
day
ht
use
still
restrict
limit
number
diagnost
laboratori
consid
cost
analysi
informat
infrastructur
need
eg
cost
sequenc
platform
comput
resourc
data
storag
despit
expand
use
ht
clinic
microbiolog
surprisingli
low
number
studi
retriev
review
might
explain
sever
reason
includ
financi
limit
consid
cost
analysi
need
shorter
turnaround
time
limit
cite
address
question
proof
causal
particularli
context
pathogen
discoveri
lipkin
propos
sever
criteria
pathogen
causal
grade
certainti
accord
confirm
serolog
assay
cultur
instanc
studi
confirm
ht
result
rt
pcr
assay
cell
cultur
serolog
assay
immunohistochemistri
thu
ht
implement
clinic
routin
associ
diagnost
test
studi
approach
establish
causal
explicitli
describ
report
tempor
associ
clinic
manifest
identif
viral
sequenc
specif
viru
use
ht
cn
sampl
time
manifest
process
describ
studi
similar
molecular
test
rt
pcr
detect
viral
sequenc
genom
clinic
sampl
interpret
caution
clinic
context
near
futur
process
establish
causal
ht
analysi
transpar
compris
multidisciplinari
session
involv
infecti
diseas
specialist
bioinformat
expert
result
concern
virus
unexpect
caus
cn
infect
final
ht
implement
clinic
routin
question
standard
address
concern
ht
protocol
data
analysi
algorithm
refer
databas
qualiti
control
prospect
studi
need
review
show
ht
contribut
identif
potenti
viral
aetiolog
enceph
meningoenceph
mening
unknown
origin
approxim
case
particular
interest
immunocompromis
patient
unbias
semiunbias
approach
led
identif
novel
virus
virus
known
expect
caus
cn
infect
standard
strategi
need
implement
ht
clinic
manag
centr
avail
decis
perform
ht
consid
earli
manag
enceph
meningoenceph
mening
secondlin
techniqu
parallel
recommend
investig
author
conflict
interest
declar
fund
receiv
studi
